Literature DB >> 14980770

Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy.

Katja Jores1, Wolfgang Mehnert, Markus Drechsler, Heike Bunjes, Christoph Johann, Karsten Mäder.   

Abstract

Recently, colloidal dispersions made from mixtures of solid and liquid lipids were described to combine controlled release characteristics with higher drug loading capacities than solid lipid nanoparticles (SLN). It has been proposed that these nanostructured lipid carriers (NLC) are composed of oily droplets which solubilize the drug and which are embedded in a solid lipid matrix. The structures of SLN and NLC based on glyceryl behenate and medium chain triglycerides were characterized by photon correlation spectroscopy (PCS) and laser diffraction (LD), field-flow fractionation (FFF) with multi-angle light scattering detection (MALS), and cryo transmission electron microscopy (cryo TEM). PCS indicates that SLN and NLC differ from a nanoemulsion with respect to Brownian motion due to asymmetric particle shapes. Non-spherical particles, in case of SLN and NLC, lead to higher polydispersity indices compared to the nanoemulsion. In FFF, the nanodroplets elute much earlier than SLN- and NLC-platelets although their PCS and LD data show similar particle sizes. In TEM platelet (for SLN), oil loaded platelet ("nanospoons"; for NLC) and droplet (for nanoemulsion) structures were observed. In contrast to literature reports, the investigated SLN appear as thin platelets. NLC are found to be lipid platelets with oil spots sticking on the surface. Very short diffusion pathways in platelets, increased water-lipid interfaces and low drug incorporation in crystalline lipids are the drawback of SLN and NLC compared to conventional nanoemulsions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980770     DOI: 10.1016/j.jconrel.2003.11.012

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  35 in total

1.  Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid.

Authors:  Uracha Ruktanonchai; Piyawan Bejrapha; Usawadee Sakulkhu; Praneet Opanasopit; Nuntavan Bunyapraphatsara; Varaporn Junyaprasert; Satit Puttipipatkhachorn
Journal:  AAPS PharmSciTech       Date:  2009-03-12       Impact factor: 3.246

2.  Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine.

Authors:  Su Li; Zhaoshuai Ji; Meijuan Zou; Xin Nie; Yijie Shi; Gang Cheng
Journal:  AAPS PharmSciTech       Date:  2011-08-03       Impact factor: 3.246

3.  Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier.

Authors:  Musallam Almoussalam; Huijun Zhu
Journal:  J Vis Exp       Date:  2016-04-26       Impact factor: 1.355

4.  SLN approach for nose-to-brain delivery of alprazolam.

Authors:  Alok Pratap Singh; Shailendra K Saraf; Shubhini A Saraf
Journal:  Drug Deliv Transl Res       Date:  2012-12       Impact factor: 4.617

5.  Isostatic ultra-high-pressure effects on supercooled melts in colloidal triglyceride dispersions.

Authors:  Christoph Blümer; Karsten Mäder
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

6.  Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy.

Authors:  Katja Jores; Annekathrin Haberland; Siegfried Wartewig; Karsten Mäder; Wolfgang Mehnert
Journal:  Pharm Res       Date:  2005-11       Impact factor: 4.200

7.  Dielectrophoretic sorting of membrane protein nanocrystals.

Authors:  Bahige G Abdallah; Tzu-Chiao Chao; Christopher Kupitz; Petra Fromme; Alexandra Ros
Journal:  ACS Nano       Date:  2013-09-09       Impact factor: 15.881

Review 8.  Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.

Authors:  Melike Uner; Gülgün Yener
Journal:  Int J Nanomedicine       Date:  2007

Review 9.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

10.  Solid lipid nanoparticles as delivery systems for bromocriptine.

Authors:  Elisabetta Esposito; Martina Fantin; Matteo Marti; Markus Drechsler; Lydia Paccamiccio; Paolo Mariani; Elisa Sivieri; Francesco Lain; Enea Menegatti; Michele Morari; Rita Cortesi
Journal:  Pharm Res       Date:  2008-01-03       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.